NCT05237947 2026-04-13
PRISMA
National Cancer Institute (NCI)
Phase 4 Active not recruiting
Clinical Trials
103 trialsNCT05651282 2026-04-13
RESToRE
University of British Columbia
Phase 4 Completed
NCT07256912 2026-03-24
CervALONE
International Agency for Research on Cancer
Phase 4 Not yet recruiting
NCT06412120 2026-03-16
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
University of Miami
Phase 4 Recruiting
NCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
NCT06952660 2026-03-12
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Phase 4 Recruiting
NCT04024254 2026-03-04
A Study of Serum Folate Levels in Patients Treated With Olaparib
Rush University Medical Center
Phase 4 Completed
NCT05334706 2026-02-23
RIFT-HPV
Institut d'Investigació Biomèdica de Bellvitge
Phase 4 Recruiting
NCT07281547 2026-02-18
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Mayo Clinic
Phase 4 Not yet recruiting
NCT07412873 2026-02-17
PROVIDENCE
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Not yet recruiting
NCT06786429 2026-01-21
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Eunice Dube
Phase 4 Not yet recruiting
NCT07015957 2026-01-12
Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention
New York University
Phase 4 Active not recruiting
NCT04145518 2025-12-12
MCUP
Endeavor Health
Phase 4 Completed
NCT06121401 2025-09-17
IOLANTHE
Mario Negri Institute for Pharmacological Research
Phase 4 Active not recruiting
NCT07075250 2025-07-20
RIFOC003
Peking University People's Hospital
Phase 4 Not yet recruiting
NCT06897527 2025-07-08
A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)
GlaxoSmithKline
Phase 4 Not yet recruiting
NCT01932125 2025-06-26
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT04861181 2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4 Terminated
NCT06972693 2025-05-15
PERSONA-Ovary
European Institute of Oncology
Phase 4 Active not recruiting
NCT05266898 2025-04-18
AGO-Gard
Louisiana State University Health Sciences Center in New Orleans
Phase 4 Recruiting
NCT06887933 2025-03-21
A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer
GlaxoSmithKline
Phase 4 Not yet recruiting
NCT03164980 2025-03-20
COMPASS
North Eastern German Society of Gynaecological Oncology
Phase 4 Terminated
NCT06871787 2025-03-14
INOCA
Istanbul University
Phase 4 Not yet recruiting
NCT04330040 2025-03-10
SOLI
AstraZeneca
Phase 4 Completed
NCT03752216 2024-12-13
NiQoLe
ARCAGY/ GINECO GROUP
Phase 4 Completed
NCT06726291 2024-12-10
NOEME
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 4 Recruiting
NCT05250648 2024-10-09
GECOP-MMC
Hospital Universitario de Fuenlabrada
Phase 4 Recruiting
NCT06536855 2024-08-05
Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda
Rwanda Biomedical Centre
Phase 4 Not yet recruiting
NCT06420258 2024-05-17
Deeper Intubation Make Effects on Cervical Esophageal ESD
Fujian Provincial Hospital
Phase 4 Recruiting
NCT06049693 2024-03-29
IROGYN
National and Kapodistrian University of Athens
Phase 4 Completed
NCT03629886 2024-03-15
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
Phase 4 Completed
NCT03051516 2024-02-28
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions
Fred Hutchinson Cancer Center
Phase 4 Terminated
NCT06031493 2024-02-28
PROVIDENCE
Hospital Clinic of Barcelona
Phase 4 Unknown
NCT05916911 2024-02-07
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Catalysis SL
Phase 4 Unknown
NCT03858166 2024-01-05
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
Shandong University
Phase 4 Terminated
NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
NCT00923702 2023-09-28
Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India
International Agency for Research on Cancer
Phase 4 Active not recruiting
NCT05926336 2023-09-28
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase 4 Recruiting
NCT01895517 2023-06-26
CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 4 Completed
NCT05606692 2023-05-30
anesthetics
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase 4 Recruiting
NCT01706120 2023-03-24
MITO16/MANGO-2
National Cancer Institute, Naples
Phase 4 Unknown
NCT04352439 2022-09-26
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Phase 4 Completed
NCT02476968 2022-09-10
ORZORA
AstraZeneca
Phase 4 Completed
NCT03794778 2022-07-18
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 4 Unknown
NCT05426148 2022-06-29
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Xiamen Innovax Biotech Co., Ltd
Phase 4 Completed
NCT01999569 2022-04-22
The Role of Estrogen in Luteinizing Hormone Surge and Ovulation
Wake Forest University Health Sciences
Phase 4 Completed
NCT00740116 2022-03-15
Tranexamic Acid in Surgery of Advanced Ovarian Cancer
University Hospital, Linkoeping
Phase 4 Completed
NCT05187208 2022-01-26
POLO
Seoul National University Hospital
Phase 4 Unknown
NCT04993924 2021-10-13
GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
Assaf-Harofeh Medical Center
Phase 4 Unknown
NCT04910802 2021-09-16
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Region Stockholm
Phase 4 Recruiting